Low dopamine D2 receptor binding in subregions of the thalamus in schizophrenia

被引:85
|
作者
Yasuno, F
Suhara, T
Okubo, Y
Sudo, Y
Inoue, M
Ichimiya, T
Takano, A
Nakayama, K
Haildin, C
Farde, L
机构
[1] Natl Inst Radiol Sci, Brain Imaging Project, Inage Ku, Chiba 2638555, Japan
[2] Tokyo Med & Dent Univ, Biofunct Informat, Grad Sch Allied Hlth Sci, Tokyo, Japan
[3] Jikei Univ, Dept Psychiat, Sch Med, Tokyo, Japan
[4] Karolinska Inst, Dept Clin & Neurosci, Psychiat Sect, Stockholm, Sweden
来源
AMERICAN JOURNAL OF PSYCHIATRY | 2004年 / 161卷 / 06期
关键词
D O I
10.1176/appi.ajp.161.6.1016
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Several structural and functional brain imaging studies have pointed to a disturbance of thalamic subnuclei in patients with schizophrenia. The dopamine hypothesis of schizophrenia has, however, not been thoroughly examined in terms of this complex structure, which has connections with most brain regions of central interest in schizophrenia research. The aim of the present study was to examine dopamine D-2 receptor binding in subregions of the thalamus in patients with schizophrenia. Method: The authors used positron emission tomography and the radioligand [C-11]FLB457 to examine dopamine D-2 receptor binding in thalamic subregions of 10 drug-naive patients with schizophrenia. Binding potential was calculated by the reference tissue method and used as an index for dopamine D-2 receptor binding. Comparisons were made with 19 healthy subjects. Subregions of interest were de-fined on individual magnetic resonance images using a percentage-based operational approach. Clinical symptoms were rated by using the Brief Psychiatric Rating Scale (BPRS). Results: The [C-11]FLB457 binding potential was lower in the central medial and posterior subregions of the thalamus in patients with schizophrenia. At a functional level, there was a significant negative correlation between binding potential and BPRS positive symptom scores. Conclusions: The subregions with low D-2 receptor binding comprise primarily the dorsomedial nucleus and pulvinar, two important components in circuitries previously suggested in the pathophysiology of schizophrenia. Aberrant dopaminergic neurotransmission in thalamic subregions might be a mechanism underlying positive symptoms in schizophrenia.
引用
收藏
页码:1016 / 1022
页数:7
相关论文
共 50 条
  • [41] The impacts of dopamine D2 receptor polymorphism and antipsychotic dosage on dopamine supersensitivity psychosis in schizophrenia
    Takase, Masayuki
    Kanahara, Nobuhisa
    Oda, Yasunori
    Niitsu, Tomihisa
    Watanabe, Hiroyuki
    Iyo, Masaomi
    SCHIZOPHRENIA RESEARCH, 2017, 190 : 182 - 183
  • [42] Bivalent Dopamine D2 Receptor Ligands: Synthesis and Binding Properties
    Kuehhorn, Julia
    Huebner, Harald
    Gmeiner, Peter
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (13) : 4896 - 4903
  • [43] Altered dopamine D2 receptor binding in atypical facial pain
    Hagelberg, N
    Forssell, H
    Aalto, S
    Rinne, JO
    Scheinin, H
    Taiminen, T
    Någren, K
    Eskola, O
    Jääskeläinen, SK
    PAIN, 2003, 106 (1-2) : 43 - 48
  • [44] Potent haloperidol derivatives covalently binding to the dopamine D2 receptor
    Schwalbe, Tobias
    Kaindl, Jonas
    Huebner, Harald
    Gmeiner, Peter
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (19) : 5084 - 5094
  • [45] Predictions of Binding for Dopamine D2 Receptor Antagonists by the SIE Method
    Wang, Yeng-Tseng
    Su, Zhi-Yuan
    Hsieh, Chang-Huain
    Chen, Cheng-Lung
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2009, 49 (10) : 2369 - 2375
  • [46] Extrastriatal Dopamine D2 Receptor Binding in Huntington's Disease
    Esmaeilzadeh, Mouna
    Farde, Lars
    Karlsson, Per
    Varrone, Andrea
    Halldin, Christer
    Waters, Susanna
    Tedroff, Joakim
    HUMAN BRAIN MAPPING, 2011, 32 (10) : 1626 - 1636
  • [47] CHARACTERIZATION OF D2 RECEPTORS AND DOPAMINE LEVELS IN THE THALAMUS OF THE RAT
    YOUNG, KA
    WILCOX, RE
    LIFE SCIENCES, 1991, 48 (19) : 1845 - 1852
  • [48] Identification of a Zn2+-binding site on the dopamine D2 receptor
    Liu, Y
    Teeter, MM
    DuRand, CJ
    Neve, KA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 339 (03) : 873 - 879
  • [49] Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia
    Hirvonen, J
    van Erp, TGM
    Huttunen, J
    Aalto, S
    Någren, K
    Huttunen, M
    Lönnqvist, J
    Kaprio, J
    Hietala, J
    Cannon, TD
    ARCHIVES OF GENERAL PSYCHIATRY, 2005, 62 (04) : 371 - 378
  • [50] Dopamine D2 receptor occupancy and cognition in schizophrenia : Analysis of the CATIE data
    Sakurai, H.
    Bies, R.
    Stroup, S.
    Keefe, R.
    Rajji, T.
    Suzuki, T.
    Mamo, D.
    Pollock, B.
    Watanabe, K.
    Mimura, M.
    Uchida, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 132 - 133